Company / Assets per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$36.41
FY2025
5-year range
$35.43 / $43.69
FY2021-FY2025
Trend
+2.8%
vs FY2024
Sector context
#31 of 210
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's assets per share of $36.41 is higher than 85% of companies in the Health Care sector (FY2025). Assets per Share returned to growth in FY2025 after 6 years of decline, reaching $36.41.
Based on SEC 10-K filings.
36.41 in FY2025 with a 5-year CAGR of -6.0%. Top quartile in the Health Care sector.
Declined from $39.28 to $36.41 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -4.6%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
-87.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 2.8% year-over-year.
- Ranks #31 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2016.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.41 | +2.8% |
| FY2024 | $35.43 | -9.8% |
| FY2023 | $39.28 | -6.4% |
| FY2022 | $41.95 | -4.0% |
| FY2021 | $43.69 | -11.9% |
| FY2020 | $49.60 | -12.3% |
| FY2019 | $56.56 | -100.0% |
| FY2018 | $63145681.58 | +90853135.8% |
| FY2017 | $69.50 | -100.0% |
| FY2016 | $96833506.76 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026